drugset / Trial / NCT02978183

Evaluation of the Effectiveness of ST266 Ophthalmic Drops Compared to Placebo to Treat Allergic Conjunctivitis

NCT02978183 ↗

Phase 2 Completed 70 enrolled Noveome Biotherapeutics
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of ST266 ophthalmic drops compared to placebo for the treatment of the signs and symptoms of allergic conjunctivitis.

Timeline

Start
2016-12
Primary completion
2017-02
Completion
2017-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator ST266 Protein / enzyme biologic — Other

Indications